Accepted Article
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density1
Ali A. Dabaja, Campbell F. Bryson, Peter N. Schlegel, Darius A. Paduch Weill Cornell Medical College, Department of Urology
Corresponding author: Darius A. Paduch [email protected] Weill Cornell Medical College, Department of Urology 525 East 68th Street, New York, NY 10065. Telephone: (212) 746-5470
Running title: alkaline phosphatase and hypogonadism
Abstract:
Objective:
To evaluate the relationship of testosterone (T) enhancing therapy on alkaline phosphatase (AP) in relation to bone mineral density (BMD) in hypogonadal men. Patients and Methods:
Retrospective review of 140 men with T
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density1
Ali A. Dabaja, Campbell F. Bryson, Peter N. Schlegel, Darius A. Paduch Weill Cornell Medical College, Department of Urology
Corresponding author: Darius A. Paduch [email protected] Weill Cornell Medical College, Department of Urology 525 East 68th Street, New York, NY 10065. Telephone: (212) 746-5470
Running title: alkaline phosphatase and hypogonadism
Abstract:
Objective:
To evaluate the relationship of testosterone (T) enhancing therapy on alkaline phosphatase (AP) in relation to bone mineral density (BMD) in hypogonadal men. Patients and Methods:
Retrospective review of 140 men with T
